Emit® 2000 Sirolimus Assay

Monitoring sirolimus levels in transplant patients is essential to ensuring the delicate balance between appropriate immunosuppression and transplant rejection. With the Emit 2000 sirolimus method, laboratories have a flexible and convenient solution to help clinicians effectively manage sirolimus therapy in their transplant patients.

Features

Simple sample pretreatment
Results in as little as 14 minutes
No reagent preparation required
Good correlation to LC/MS/MS

Advantages

Streamlined ISD monitoring and enhanced productivity
Excellent analytical performance for confidence in results
Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system*

Assay Specifications

	Emit 2000 SIRO Assay
Product Code	8S019UL
Sample Type	EDTA Whole Blood
Pretreatment	Manual
Reportable Range	3.5 -30 ng/mL
Calibration	With new reagent lot
Reagent Stability	Opened at 2-8° C: 4 weeks

*Not all assays available in all countries. Check with your local Siemens Healthcare Diagnostics representative for assay availability.

Download Spec Sheet[93 KB]

Learn more about the V-Twin® and Viva-E® Drug Testing Systems

Enduring Expertise for Your Immunosuppressant Drug Testing Needs

With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.

Learn more about the ISD offerings from Siemens
Learn more about organ transplantation
Learn more about ISD monitoring
Learn more about sirolimus